Report adverse events:

Adverse events should be reported to the Vifor Pharma group.
safety@viforpharma.com

Consent form for HCPs

If you, as an HCP, wish to receive electronic promotional and non-promotional information from the Vifor Pharma Group, please subscribe using this form.

National HCP number (if applicable)

Country

*Required fields

Select the channels through which you agree to receive the communications and specify the corresponding contact details:

E-mail

SMS

Fax

Please fill in all required fields

Please select a country

Please confirm that you have read Vifor Pharma Group's privacy notice

The email address is not correct

Make sure your number is correct, starting with "+" and the country code

Please select a communication channel

Please enter captcha

Captcha entered is not valid

Server Error - Your submission was not sent

CAPTCHA

Math question 2 + 6 =

Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

I hereby consent to receive communications from the Vifor Pharma Group, including promotional and non-promotional information, through the channels I have selected above, as specified in the Privacy Notice

The information and materials for Veltassa contained in this website were prepared based on the EU SmPC. Prescribing information may vary depending on local approval in each country. Therefore, before prescribing any product, always refer to local materials such as the prescribing information and/or the Summary of Product Characteristics (SPC).

Vifor Fresenius Medical Care Renal Pharma (VFMCRP) Ltd, a company of the Vifor Pharma Group, is the partner of choice for renal pharmaceutical and innovative, patient-focused solutions. The Vifor Pharma Group is a global pharmaceuticals company. It aims to become the global leader in iron deficiency, nephrology and cardio-renal therapies. The Vifor Pharma Group strives to help patients around the world with severe and chronic diseases lead better, healthier lives. The company develops, manufactures and markets pharmaceutical products for precision patient care. The Vifor Pharma Group holds a leading position in all its core business activities and consists of the following companies: Vifor Pharma; Vifor Fresenius Medical Care Renal Pharma, a joint company with Fresenius Medical Care; Relypsa; and 0M Pharma. For more information about Vifor Pharma, please visit www.viforpharma.com

This site does not provide medical advice and may not be relied upon by any healthcare practitioner in exercising his or her professional judgement in the practice of medicine. The information provided herein is provided for general educational purposes only, and is not to be used or relied on for any diagnostic or treatment purposes. This material is not intended to represent the best or only methods or procedures appropriate for the medical situations discussed; rather the material is intended to present an approach, view, statement or opinion of the authors or presenters, which may be helpful or of interest to other practitioners. VFMCRP makes no warranties or representations as to the site’s accuracy, completeness or up-to-date information. All users agree that access to this site is at their own risk, and that neither VFMCRP any party involved in creating or delivering this site shall be liable for damages of any kind, including without limitation, any special, direct or indirect, incidental, or consequential or punitive damages (even if VFMCRP has been advised of the possibility of such damages) arising out of access to, or use of the information contained on this site, or any errors or omissions, misprints, out-of-date information, technical or pricing inaccuracies, typographical or other errors appearing on this site. This limitation includes damages to, or for any viruses that may infect your computer equipment.
© 2019 Vifor Fresenius Medical Care Renal Pharma

Terms of use Privacy policy Cookie policy Prescribing information COOKIE SETTINGS

HQ-PAT-2000046 | Date of preparation: December 2020